HOME >> BIOLOGY >> NEWS
AHA Issues Scientific Statement On Infective Endocarditis

American Heart Association Journal Report:

DALLAS, Dec. 22 -- The American Heart Association today issues a new scientific statement that updates the procedures for diagnosing and treating infective endocarditis, a life-threatening heart infection that can be caused by common microbes such as streptococcus or "strep."

The statement by the AHA's Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease is published in today's Circulation: Journal of the American Heart Association.

Infective endocarditis (IE) occurs when bacteria or fungus cause severe infections in the inner lining of the heart or heart valves, leading to tissue damage or destruction. Antibiotics can usually treat the bacterial infections, but if the disease is not detected, the infection can gradually destroy the heart lining or heart valves. Also, clumps of the bacteria can break off and travel through the blood vessels to other organs, including the brain. This can cause serious injury to these organs or even death.

About 20,000-30,000 people develop IE, a disease that represents the fourth leading cause of life-threatening infections such as pneumonia, according to Kathryn A. Taubert, Ph.D., senior scientist in the AHA's department of science and medicine and a co-author of the statement.

Individuals at risk for IE include people with certain defects of the heart present at birth, heart valve disorders, mitral valve prolapse, a history of rheumatic heart disease, or anyone who has an artificial heart valve.

Individuals who are intravenous drug abusers are also at high risk for IE. The statement is the first from the American Heart Association to recommend the set of diagnostic criteria for IE developed by researchers at Duke University Medical Center. The previous diagnostic criteria relied on tests that measured bacteremia (high amounts of bacteria in the blood), regurgitant murmur (a heart abnormality) and blood vessel complications. The ne
'"/>

Contact: Brian Henry
brianh@heart.org
214-706-1135
American Heart Association
21-Dec-1998


Page: 1 2

Related biology news :

1. Immigration and Travel Issues for Foreign Scientists and Technology Workers
2. Trade, science, risk, precaution: Issues for Seattle
3. Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry
4. USGS Issues Wildlife Health Alert: Associates Virus With Salamander Die-Offs
5. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues
6. China And USGS--Working Together On Environmental Issues
7. Antimicrobial Resistance: Issues And Options
8. American Museum Of Natural History Holds Symposium On Biodiversity And Human Health Issues
9. 2nd media alert First Scientific Conference on Childhood Leukaemia
10. First International Scientific Conference on Childhood Leukaemia
11. Scientific publications: Time for change

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2019)... ... May 22, 2019 , ... ... helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... with Industrial Production Processes (IPP) Ltd has been signed. The agreement ...
(Date:5/21/2019)... ... , ... Experiential tourism, a trend encompassing culinary travel, cultural exploration and activity-based ... And according to a recent report by Skift, a media company for the travel ... travelers are wanting their journeys to be authentic and unique, and good cuisine has ...
(Date:5/21/2019)... ... May 21, 2019 , ... Zer0 to ... 20 today, and to celebrate launched a new startup package, 0to5 Launch, to ... need – pre-product – to attract talent and investors. , “We launched our ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted Danson ... scheduled to broadcast 4Q/2019. Check your local listings for more information. , Advancements ... how its technology facilitates laboratories to improve efficiency and quality of research by ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the leader in ... in opioid treatment, announced today they are partnering to combat the opioid crisis ... its virtual care platform at the Mayo Clinic to drive shared decision making ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today in ... are able to incorporate into human CD34+ cells, modifying their gene expression and ... increased the cells’ ability to lodge into bone marrow. This research performed by ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of cancer ... breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor ... T cell receptors known as “CARs”. The CAR enables the final product to produce ...
Breaking Biology Technology:
Cached News: